Assessment of the efficacy and oncological safety of sentinel lymph node biopsy in node-negative breast cancer using methylene blue dye

Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center

Evaluation of the Efficacy of Combined Sentinel Lymph Node Biopsy Using Patent Blue Dye and Peripheral Lymph Node Biopsy in Management of Nodal Negative Early Breast Cancer

Evaluation of sentinel lymph node biopsy using 1% methylene blue in node-responsive postneoadjuvant chemotherapy in patients with breast cancer

SENTINEL LYMPH NODE BIOPSY USING METHYLENE BLUE DYE IN EARLY BREAST CANCER. IS IT TRULY RELIABLE?

SENTINEL LYMPH NODE BIOPSY AS A PROGNOSTIC TOOL IN EARLY ORAL CANCER USING METHYLENE BLUE DYE

Assessment of accuracy of axillary sentinel lymph node biopsy in medially located breast cancer using methylene blue injection technique: our institute experience

SUBAREOLAR VERSUS PERITUMORAL INJECTION OF METHYLENE BLUE FOR SENTINEL LYMPH NODE DETECTION IN CASES OF EARLY BREAST CANCER

Carbon nanoparticles versus patent blue dye for detection of sentinel lymph node in patients with early breast cancer

Evaluation of targeted axillary dissection following neoadjuvant therapy for a patient with node-positive breast cancer as initial experience in Ain Shams University Hospitals